DR. SCHOLL'S(R) FOR HER Joins Forces With Style Expert Stacy London to Help Women Achieve Style and Comfort

WHITEHOUSE STATION, N.J., April 8 /PRNewswire-FirstCall/ -- Schering-Plough Consumer HealthCare, a subsidiary of Merck & Co., Inc., today announced the launch of the DR. SCHOLL'S® FOR HER Challenge, inviting women to experience the difference DR. SCHOLL'S® FOR HER Insoles can make, even in their most uncomfortable shoes. With the help of Stacy London, style expert and host of TLC's "What Not To Wear," the campaign will distribute more than 3 million free insoles to show women across America that they can achieve both comfort and style at the same time.

To view the multimedia assets associated with this release, please click http://www.prnewswire.com/news-releases/dr-schollsr-for-her-joins-forces-with-style-expert-stacy-london-to-help-women-achieve-style-and-comfort-89731562.html

"It's no secret that women love their shoes, but we also know they can be a pain in the foot," said London. "That's why I use DR. SCHOLL'S® FOR HER Insoles to cushion my feet because I'm a firm believer that you should never have to sacrifice comfort for fashion. I'm excited the brand is offering women a free insole so they can really feel the difference for themselves like I have."

Consumers can sign up for a free insole on the brand's new DR. SCHOLL'S® FOR HER Facebook Page at www.facebook.com/drschollsforher.  The page also offers tips for looking and feeling fabulous, including product information and comfort tips from Stacy London. On a mission to change the way it feels to be in heels, DR. SCHOLL'S® FOR HER will also run a print advertising campaign featuring London that will sample one free insole in select magazines.

"Ever since DR. SCHOLL'S® FOR HER debuted as the first and only complete footcare line designed specifically for women, we've strived to help women understand that they don't have to tolerate uncomfortable shoes," said T.J. Higgins, Vice President of Marketing for DR. SCHOLL'S® FOR HER. "We're challenging women to try a free insole because once they experience the difference, they will be one step closer to realizing that they can achieve comfort in any shoe style."

Dr. Scholl's® For Her products are available in the footcare aisle at most food, drug and mass stores nationwide. For more information, visit http://www.drschollsforher.com.

About DR. SCHOLL'S®

DR. SCHOLL'S® is America's #1 brand of footcare products, providing comfort to millions for over a century. Today, DR. SCHOLL'S® FOR HER is proud to be the first and only full line of footcare products designed specifically for women.  From pedicure products to insoles for your favorite pair of heels, DR. SCHOLL'S® FOR HER enables women to look and feel fabulous.

About Stacy London

Stacy London is one of America's premier style experts, helping women to boost their confidence by creating and celebrating their personal style.  She joined TLC in 2002 as one of the original hosts of "What Not Wear," after years of styling experience for fashion publications including Vogue and Mademoiselle. She has worked with celebrities such as Kate Winslet and Katie Holmes and consulted for designers such as Vivienne Tam and Rebecca Taylor. In addition to her role on "What Not to Wear," Stacy is a style correspondent for NBC's TODAY Show, regular commentator for Access Hollywood, and contributing editor for People Magazine.

About Schering-Plough Consumer HealthCare

Today's Merck is working to help the world be well. Schering-Plough Consumer HealthCare is a subsidiary of Merck & Co., Inc. Each day, millions count on one or more of our industry-leading brands that help prevent or treat various common conditions. These include household names such as CLARITIN® for allergies, COPPERTONE® for sun care, DR. SCHOLL'S® for foot care, and many more. Merck. Be well. For more information, visit www.merck.com.

Forward-Looking Statement

This news release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such statements may include, but are not limited to, statements about the benefits of the merger between Merck and Schering-Plough, including future financial and operating results, the combined company's plans, objectives, expectations and intentions and other statements that are not historical facts. Such statements are based upon the current beliefs and expectations of Merck's management and are subject to significant risks and uncertainties. Actual results may differ from those set forth in the forward-looking statements.

The following factors, among others, could cause actual results to differ from those set forth in the forward-looking statements: the possibility that the expected synergies from the merger of Merck and Schering-Plough will not be realized, or will not be realized within the expected time period, due to, among other things, the impact of pharmaceutical industry regulation and pending legislation that could affect the pharmaceutical industry; the risk that the businesses will not be integrated successfully; disruption from the merger making it more difficult to maintain business and operational relationships; Merck's ability to accurately predict future market conditions; dependence on the effectiveness of Merck's patents and other protections for innovative products; the risk of new and changing regulation and health policies in the U.S. and internationally and the exposure to litigation and/or regulatory actions.

Merck undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in Merck's 2009 Annual Report on Form 10-K and the company's other filings with the Securities and Exchange Commission (SEC) available at the SEC's Internet site (www.sec.gov).

SOURCE Merck & Co., Inc.

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED